What is the treatment regimen for amoebiasis using Diloxanide furoate syrup?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diloxanide Furoate Syrup for Amoebiasis

Diloxanide furoate should be administered at 500 mg orally three times daily for 10 days in adults as a luminal amebicide following tissue-active treatment with metronidazole, or as monotherapy for asymptomatic cyst passers. 1

Treatment Algorithm

For Symptomatic Intestinal Amoebiasis (Confirmed Trophozoites)

Initial tissue-active therapy:

  • Adults: Metronidazole 750 mg three times daily for 5-10 days 2, 1
  • Children: Metronidazole 30 mg/kg/day for 5-10 days 2, 1

Mandatory follow-up luminal therapy (after metronidazole completion):

  • Diloxanide furoate 500 mg orally three times daily for 10 days to eliminate intestinal cysts and prevent relapse 1
  • Alternative: Paromomycin 30 mg/kg/day orally in 3 divided doses for 10 days 1

For Asymptomatic Cyst Passers

Diloxanide furoate monotherapy is the treatment of choice:

  • 500 mg orally three times daily for 10 days 1, 3
  • Achieves 86-93% parasitological cure rates in asymptomatic patients 4, 5
  • Significantly more effective than metronidazole/tinidazole for asymptomatic carriage (93% vs 29-56% cure rates) 4

Pediatric Dosing Considerations

While the evidence primarily describes adult dosing at 500 mg three times daily, children may require weight-based dosing adjustments though specific pediatric syrup dosing is not explicitly detailed in the available guidelines 5. The drug is particularly well tolerated in children aged 20 months to 10 years, with only 3% reporting adverse effects compared to 12% in adults 5.

Safety Profile

Common adverse effects (reported in 14% of treatment courses): 5

  • Flatulence (most common)
  • Diarrhea or cramping
  • Nausea
  • Headache (less common)
  • Disorientation, dizziness, or diplopia (rare)

The drug demonstrates excellent tolerability, especially in pediatric populations 5

Critical Clinical Pitfalls

Do not use metronidazole alone for intestinal amoebiasis - it achieves only 29-56% cure rates in asymptomatic patients and requires follow-up luminal therapy 4. Failure to administer diloxanide furoate after metronidazole risks relapse from persistent intestinal cysts 1, 3.

Confirm diagnosis before treatment - only treat after microscopic identification of amebic trophozoites or after failure of two different antibiotics for presumed shigellosis 2, 1. Amebic dysentery is frequently misdiagnosed 2.

Treatment Monitoring

Assess clinical response within 2 days - if no improvement occurs, consider alternative diagnoses or drug resistance 1. Follow-up stool examination should be performed at least 14 days post-treatment to confirm parasitological cure 5.

References

Guideline

Treatment of Amoebiasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Therapy of entamebiasis.

Journal of chemotherapy (Florence, Italy), 1989

Research

Diloxanide furoate for treating asymptomatic Entamoeba histolytica cyst passers: 14 years' experience in the United States.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.